Prevalence of SARS-CoV-2 antibodies in France: results from nationwide serological surveillance

Assessment of the cumulative incidence of SARS-CoV-2 infections is critical for monitoring the course and extent of the COVID-19 epidemic. Here, we report estimated seroprevalence in the French population and the proportion of infected individuals who developed neutralising antibodies at three point...

Descripción completa

Detalles Bibliográficos
Autores principales: Le Vu, Stéphane, Jones, Gabrielle, Anna, François, Rose, Thierry, Richard, Jean-Baptiste, Bernard-Stoecklin, Sibylle, Goyard, Sophie, Demeret, Caroline, Helynck, Olivier, Escriou, Nicolas, Gransagne, Marion, Petres, Stéphane, Robin, Corinne, Monnet, Virgile, Perrin de Facci, Louise, Ungeheuer, Marie-Noelle, Léon, Lucie, Guillois, Yvonnick, Filleul, Laurent, Charneau, Pierre, Lévy-Bruhl, Daniel, van der Werf, Sylvie, Noel, Harold
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8140151/
https://www.ncbi.nlm.nih.gov/pubmed/34021152
http://dx.doi.org/10.1038/s41467-021-23233-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8140151/
https://www.ncbi.nlm.nih.gov/pubmed/34021152
http://dx.doi.org/10.1038/s41467-021-23233-6

Ejemplares similares